Indonesia Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Indonesia Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Indonesia Clinical Nutrition for Diabetes Care Market was valued at $12.90 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $17.89 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Danone SA, Perrigo Company, and Abbott Nutrition among others.

ID: IN10IDPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Avantika Gupta

Buy Now

Indonesia Clinical Nutrition for Diabetes Care Market Executive Summary

The Indonesia Clinical Nutrition for Diabetes Care Market is at around $12.90 Mn in 2023 and is projected to reach $17.89 Mn in 2030, exhibiting a CAGR of 4.78% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Danone SA is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, B.Braun Melsungen AG, and Novo Nordisk are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Indonesia Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Prevalence of Diabetes: Indonesia has seen a significant increase in the number of people with diabetes in recent years. According to the International Diabetes Federation, roughly 10.6% of adults are living with diabetes. This growing diabetes prevalence is a major driver for the clinical nutrition market, as proper nutrition is crucial for managing blood sugar levels and preventing complications.

Technological Advancements: Ongoing advancements in clinical nutrition, such as the development of specialized dietary supplements and the increasing use of digital health tools for personalized nutrition plans, are making diabetes management more effective. Supplements with targeted nutrients like chromium, magnesium, and vitamin D, have been shown to enhance insulin sensitivity and glucose control. These innovations are expected to drive the adoption of clinical nutrition interventions among healthcare providers and patients in Indonesia.

Collaborations and Initiatives: The National Diabetes Program is a national program developed by the Ministry of Health to address diabetes prevention, control, and complications. This includes early detection through Posbindu PTM (integrated health posts) and promoting healthy lifestyles. Changing Diabetes in Children (CDiC) Indonesia is a partnership program between the government, and Novo Nordisk that aims to improve access to care for children with type 1 diabetes.

Market Restraints

Lack of Awareness: Many people with diabetes in Indonesia lack awareness about the importance of proper nutrition in managing their condition. There may still be a gap in understanding the specific benefits of clinical nutrition for managing diabetes. Also, traditional beliefs and cultural practices regarding food may lead to resistance to adopting specialized diabetic diets or relying on clinical nutrition products.

Accessibility Challenges: Access to quality clinical nutrition services and products is limited, especially in rural and underserved areas of Indonesia. Remote areas have limited access to healthcare facilities and the availability of registered dietitians, who play a crucial role in providing personalized nutrition assessments, counseling, and education for people with diabetes is also limited. This hinders the effective integration of these products into a patient's diabetes management plan.

Regulatory Challenges: The clinical nutrition market is subject to stringent regulations governing the development, manufacturing, and marketing of these specialized products. The process for obtaining regulatory approval for new clinical nutrition products is lengthy and challenging, potentially delaying the availability of innovative solutions in the market.

Regulatory Landscape and Reimbursement Scenario

The regulatory landscape for clinical nutrition for diabetes care products in Indonesia is overseen by the Indonesian Food and Drug Authority (BPOM). Regulation No. 30/2013 on the Inclusion of Nutrition in the National Health Insurance (JKN) program, which covers the provision of clinical nutrition services for certain medical conditions, including diabetes. All clinical nutrition products, including specialized foods and beverages for diabetes, require registration with BPOM before being marketed in Indonesia. The registration process involves submitting detailed information about the product's composition, safety data, and intended use. Labels on clinical nutrition products must comply with Indonesian regulations. This includes information on ingredients, nutritional content, serving size, and any specific claims related to diabetes management.

Jaminan Kesehatan Nasional (JKN) or National Health Insurance is a program that provides basic health coverage to a large portion of the Indonesian population. It covers the cost of medical nutrition therapy provided by licensed nutritionists and dietitians and dietary counseling and education for patients with diabetes. Program Pengendalian Penyakit Kronis (Prolanis) specifically targets chronic diseases like diabetes and hypertension. It aims to provide more comprehensive and continuous care for patients enrolled in JKN.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Danone SA
Perrigo Company
Nestlé Health Science
B.Braun Melsungen AG
PT Kalbe Farma
Sanofi
PT SOHO Global Health
Nutricia Indonesia
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.